top
Search terms
Results 41 - 50 of 117 - ordered by :
Pages: 1 ... 2 3 4 5 6 7 8 ... 12
Ehjcvp

The EMPA-REG outcome trial showed improved survival and less hospitalization for HF: it is changing concepts and practice.1 The new era of outcome trials follows the acute awareness of the need to ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Basil S. Lewis

Date : 01/10/2016 Item size : 203582 bytes
Ehjcvp

In situations where the fundamental pathology is associated with increased thrombolytic activity, D-dimer assays could serve an integral role in the clinical workup, and have an already established ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Armaghan Y. Soomro, Alejandra Guerchicoff, Dru J. Nichols, Javed Suleman, George D. Dangas

Date : 01/07/2016 Item size : 353592 bytes
Ehjcvp

Given the burden of cardiovascular disease in patients with diabetes, the focus should shift towards cardiovascular outcome studies designed to evaluate efficacy (i.e. to determine the efficacy of a ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Faiez Zannad, Wendy Gattis Stough, Raymond J. Lipicky, Juan Tamargo, George L. Bakris, Jeffrey S. Borer, Maria de los Angeles Alonso ...

Date : 01/07/2016 Item size : 285307 bytes
Ehjcvp

SerelaxinAcute heart failureCongestion reliefOrgan protectionLong-term outcomesIntroduction Heart failure (HF) is a chronic condition, punctuated by acute episodes, which affects as many as one in ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Javier Díez, Luis M. Ruilope

Date : 01/04/2016 Item size : 577165 bytes
Ehjcvp

Abstract Aims Non-ST-elevation acute coronary syndrome (NSTE-ACS) is present in about 6070% of patients admitted with acute coronary syndromes in clinical practice. The current guidelines of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Uwe Zeymer, Petr Widimsky, Nicolas Danchin, Maddalena Lettino, Alfredo Bardaji, Jose A. Barrabes, Angel Cequier, Marc J. ...

Date : 01/10/2016 Item size : 357401 bytes
Ehjcvp

Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients Patients on digitalis were more ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Julia W. Erath, Mate Vamos, Stefan H. Hohnloser

Date : 01/07/2016 Item size : 225615 bytes
Ehjcvp

[...]SGLT2 inhibition represents a novel treatment, which might be a promising target not only to (further) reduce blood glucose but also to target other cardiovascular risk factors. SGLT2 ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Anne E. de Leeuw, Rudolf A. de Boer

Date : 18/04/2016 Item size : 590679 bytes
Ehjcvp

Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER The aim of this study was to use individual ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Björn W. Karlson, Olov Wiklund, Michael K. Palmer, Stephen J. Nicholls, Pia Lundman, Philip J. Barter

Date : 29/03/2016 Item size : 169375 bytes
Ehjcvp

The multiorgan targets of melatonin, as here reviewed and as shown in Figure 1, have important implications for optimal health at a time when cardiovascular diseases (CVDs) are the main causes of ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Lionel H. Opie, Sandrine Lecour

Date : 06/08/2016 Item size : 351968 bytes
Ehjcvp

Annual report of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy Nucleus composition Chairperson Stefan Agewall, Norway Vice-chairperson Basil S. Lewis, Israel ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Basil S. Lewis, Stefan Agewall

Date : 01/01/2016 Item size : 109861 bytes